packageLixisenatide

lixisenatide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lixisenatide is a glucagon-like peptide-1 agonist used as an anti-diabetic medication for type 2 diabetes. It is an approved injectable diabetes drug, authorised in the European Union, although one product there has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q6659956 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lixisenatide
ATC codes:A10BJ03
DrugBank:DB09265
PubChem CID:131704317
ChEBI:85662
Wikidata:Q6659956
molar mass:4858 g/mol (Drugs.Common 25.09, not verified)
logP:-30.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown